Neurable, a Boston-based neurotechnology company, has secured $13M in funding.

Investors include Ultratech Capital Partners, TRAC, Pace Ventures, and Metaplanet.

The funds will bolster Neurable’s platform development, allowing OEMs and companies access to advanced non-invasive BCI technology, aiming to make it widely available to consumers.

Led by CEO Dr. Ramses Alcaide, the company specializes in AI-powered brain signal translation and BCI technology, pushing forward innovations in earbuds, helmets, and head-worn devices to optimize human performance.

With over $30M in funding to date, Neurable collaborates with Air Force Research Lab’s 711 Human-Performance Wing and has secured $5M from the Department of Defense to enhance soldier health and performance.